Diabetes and cancer: clinical implications for integrated metabolic–oncologic care - Top-Institutions - MDSpire

Diabetes and cancer: clinical implications for integrated metabolic–oncologic care

  • By

  • Vanessa Fuchs-Tarlovsky

  • May 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Endocrinology

  • #3

    City of Hope
    City of Hope

    Duarte, California

    Key Differentiators

    • Oncology
    • Endocrinology

Original Source(s)

Diabetes and cancer: clinical implications for integrated metabolic–oncologic care

  • by Vanessa Fuchs-Tarlovsky

  • May 1, 2026

Related Content

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment